Group items tagged

Decline birth rate worldwide has led to the increasing adoption of various human reproductive technologies. For instance, according to the World Bank, Japan's birth rate, crude (per 1,000 people) decreased from 8.413 in 2005 to 7.4 in 2018. On the other hand, the increasing population has also led to the approval and launch of contraception products. In May 2020, Evofem Biosciences, Inc. received the U.S. Food and Drug Administration (FDA) approval for Phexxi (lactic acid, citric acid and potassium bitartrate) vaginal gel used to prevent pregnancy in females of reproductive potential for use as an on-demand method of contraception. As the use of human reproductive technologies advances, there is increasing concern about ethical issues surrounding these medical interventions. While the use of fertility medication has been approved by the FDA, there are still questions about how to regulate it because of the fact that it is not a prescription and because of the inherent risks associated with using the technology. The first thing that we need to recognize is that the technology of artificial insemination has been around for decades. The only difference today is that we now have the ability to use technology to assist in the process of getting pregnant. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/declining-birth-rate-and-increasing.html

The program had no impact on the clinical management of these patients or the frequency of adverse events. Program developers nonetheless believe the approach could be highly effective if the alerts and decision support were better integrated into existing workflow and the system made easier to use. They are working on these refinements and plan to test a revamped program in the future.